Literature DB >> 31524853

Tobacco Control in Cancer Care.

Shu-Ching Chen.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31524853      PMCID: PMC6752696          DOI: 10.1097/JNR.0000000000000353

Source DB:  PubMed          Journal:  J Nurs Res        ISSN: 1682-3141            Impact factor:   1.682


× No keyword cloud information.
Tobacco smoking has been directly associated with many types of cancer. Six million people die from tobacco smoking globally each year (World Health Organization, 2019), and according to the Centers for Disease Control and Prevention's Division of Cancer Prevention and Control, more than 600,000 patients are diagnosed with and around 350,000 patients die from tobacco-related cancers in the United States each year (Centers for Disease Control and Prevention, 2019). In Taiwan, an estimated 18.0% of adults smoke tobacco, which is known to negatively affect human health and to be a risk factor for cancer (Health Promotion Administration, Ministry of Health and Welfare, ROC, 2018). Controlling tobacco consumption reduces cancer risk, promotes early cancer detection, increases treatment efficacy, improves treatment-related toxicity, controls disease progression, prevents cancer recurrence, reduces the risk of secondary cancers, and increases survival and quality of life (Gajdos et al., 2012). Although healthcare providers implement tobacco control measures in oncology settings, a national survey by a cancer institute in the United States revealed that only 62% of cancer institutes provided tobacco educational materials routinely to patients. Moreover, over half of those that routinely provided these materials maintained an effective identification system to detect patient tobacco use, with the remaining institutes either having an employee on staff who was dedicated to providing tobacco use reduction services or having an executive team that was committed to providing tobacco use treatment services (Goldstein, Ripley-Moffitt, Pathman, & Patsakham, 2013). Tobacco control is a considerable challenge in cancer care, and the lack of appropriate tobacco control measures may limit the effectiveness of this care. In this issue of The Journal of Nursing Research, Kurt and Akyuz evaluate whether educational brochure intervention increased the number of women who were screened for cervical cancer. The brochure-and-education group attained higher knowledge scores and a higher cervical cancer screening rate than the other two groups. This finding may encourage healthcare providers to provide cancer preventive care education and materials to patients and facilitate the early detection of cancers. Future studies should identify the smoking status and tobacco-control-related information that is most useful for inclusion in these educational brochures. In addition, Tsai et al. analyzed the Assessment of Survivor Concerns scale for gynecological cancer survivors, revealing that cancer survivors are concerned about secondary cancers, cancer recurrence, and overall health status. Thus, tobacco control is crucial to attaining effective survivorship care and increasing patient survival and quality of life.
  2 in total

1.  Adverse effects of smoking on postoperative outcomes in cancer patients.

Authors:  Csaba Gajdos; Mary T Hawn; Elizabeth J Campagna; William G Henderson; Jasvinder A Singh; Thomas Houston
Journal:  Ann Surg Oncol       Date:  2011-11-08       Impact factor: 5.344

2.  Tobacco use treatment at the U.S. National Cancer Institute's designated Cancer Centers.

Authors:  Adam O Goldstein; Carol E Ripley-Moffitt; Donald E Pathman; Katharine M Patsakham
Journal:  Nicotine Tob Res       Date:  2012-04-11       Impact factor: 4.244

  2 in total
  1 in total

1.  Body mass index and self-care behaviors related to oral health-related quality of life in patients with oral squamous cell carcinoma within three months posttreatment.

Authors:  Bing-Shen Huang; Ching-Fang Chung; Ya-Lan Chang; Li-Yun Lee; Hsi-Ling Peng; Shu-Ching Chen
Journal:  Support Care Cancer       Date:  2020-09-10       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.